PODD vs. SOLV: Insulet vs. Solventum Stock Comparison
How do Insulet (PODD) and Solventum (SOLV) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Insulet (PODD) and Solventum (SOLV) both belong to the Health Care Equipment & Supplies industry, though PODD is classified under Health Care Equipment while SOLV falls under Health Care Supplies.
Insulet (PODD) has been public since May 15, 2007, giving it a longer listed trading history, while Solventum (SOLV) listed on March 26, 2024 and still has a shorter public-market record.
| Profile Item | PODD | SOLV |
|---|---|---|
| Name | Insulet Corporation | Solventum Corporation |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Supplies |
| Market Capitalization | 10.16 billion USD | 15.36 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | May 15, 2007 | March 26, 2024 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | PODD | SOLV |
|---|---|---|
| Total Return (1Y) | -53.25% | 25.89% |
| Total Return (3Y, Annualized) | -0.74% | -- |
| Total Return (5Y, Annualized) | -14.02% | -- |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | PODD | SOLV |
|---|---|---|
| Volatility (1Y, Annualized) | 46.33% | 30.06% |
| Beta (5Y) | 1.04 | 0.62 |
| Max Drawdown (5Y) | -63.02% | -39.98% |
| Avg. Volume (3M) | 1.58M | 1.05M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | PODD | SOLV |
|---|---|---|
| Sharpe Ratio (1Y) | -1.24 | 0.72 |
| Sortino Ratio (1Y) | -1.51 | 1.08 |
Profitability
ROE (TTM)
Insulet (PODD) at 28.94% sits in the top ROE quartile, while Solventum (SOLV) at 3.19% is closer to the peer norm — stronger capital efficiency for PODD.
PODD
Health Care Equipment & Services industry group
28.94%
- Max
- 47.61%
- PODD
- 28.94%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
SOLV
Health Care Equipment & Services industry group
3.19%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- SOLV
- 3.19%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Insulet (PODD) at 13.44% retains a top-quartile share of revenue as profit, ahead of Solventum (SOLV) at 1.91%, which keeps about the industry-typical share.
PODD
Health Care Equipment & Services industry group
13.44%
- Max
- 29.35%
- PODD
- 13.44%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
SOLV
Health Care Equipment & Services industry group
1.91%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- SOLV
- 1.91%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Insulet (PODD) at 22.54% operates in the top operating margin quartile, ahead of Solventum (SOLV) at 6.82%, which runs around its industry’s norm.
PODD
Health Care Equipment & Services industry group
22.54%
- Max
- 35.43%
- PODD
- 22.54%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
SOLV
Health Care Equipment & Services industry group
6.82%
- Max
- 35.43%
- Q3
- 14.14%
- SOLV
- 6.82%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | PODD | SOLV |
|---|---|---|
| ROE (TTM) | 28.94% | 3.19% |
| ROA (TTM) | 11.40% | 2.29% |
| Net Margin (TTM) | 13.44% | 1.91% |
| Operating Margin (TTM) | 22.54% | 6.82% |
| Gross Margin (TTM) | 71.88% | 55.13% |
Growth
Revenue Growth
Insulet (PODD) at 30.73% sits in the top revenue growth quartile, while Solventum (SOLV) at 0.86% is in the bottom quartile, showing a clear gap in revenue momentum.
EPS Growth
Solventum (SOLV) at 221.74% delivers above-range EPS growth, while Insulet (PODD) at -39.79% falls into the bottom quartile — a wide split in earnings momentum.
Growth Metrics
| Metric | PODD | SOLV |
|---|---|---|
| Revenue Growth (YoY) | 30.73% | 0.86% |
| Revenue Growth (3Y CAGR) | 27.54% | 0.79% |
| EPS Growth (YoY) | -39.79% | 221.74% |
| EPS Growth (3Y CAGR) | 267.70% | 4.51% |
Financial Strength
Current Ratio (MRQ)
Insulet (PODD) at 2.51 keeps current ratio within its industry’s typical mid-range, while Solventum (SOLV) at 1.03 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for SOLV.
PODD
Health Care Equipment & Services industry group
2.51
- Max
- 7.59
- Q3
- 4.00
- PODD
- 2.51
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
SOLV
Health Care Equipment & Services industry group
1.03
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- SOLV
- 1.03
- Min
- 0.30
Debt / Equity (MRQ)
Insulet (PODD) at 0.66 carries an industry-typical debt-to-equity mix, while Solventum (SOLV) at 1.10 uses more debt funding than most peers.
PODD
Health Care Equipment & Services industry group
0.66
- Max
- 1.88
- Q3
- 0.91
- PODD
- 0.66
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
SOLV
Health Care Equipment & Services industry group
1.10
- Max
- 1.88
- SOLV
- 1.10
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | PODD | SOLV |
|---|---|---|
| Current Ratio (MRQ) | 2.51 | 1.03 |
| Debt / Equity (MRQ) | 0.66 | 1.10 |
| Net Debt / EBITDA | 0.65 | 4.66 |
Dividends
Dividend Yield (TTM)
Neither Insulet (PODD) nor Solventum (SOLV) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
PODD
Health Care Equipment & Services industry group
0.00%
- PODD
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
SOLV
Health Care Equipment & Services industry group
0.00%
- SOLV
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither Insulet (PODD) nor Solventum (SOLV) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
PODD
Health Care Equipment & Services industry group
0.00%
- PODD
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
SOLV
Health Care Equipment & Services industry group
0.00%
- SOLV
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | PODD | SOLV |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
Insulet (PODD) at 23.94 is near its industry’s usual P/E ratio, while Solventum (SOLV) at 101.55 sits above its peer range — an unusually expensive price for SOLV’s trailing earnings.
PODD
Health Care Equipment & Services industry group
23.94
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- PODD
- 23.94
- Q1
- 21.19
- Min
- 4.21
SOLV
Health Care Equipment & Services industry group
101.55
- SOLV
- 101.55
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
On P/S ratio, both Insulet (PODD) at 3.19 and Solventum (SOLV) at 1.88 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.
PODD
Health Care Equipment & Services industry group
3.19
- Max
- 8.80
- Q3
- 4.32
- PODD
- 3.19
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
SOLV
Health Care Equipment & Services industry group
1.88
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- SOLV
- 1.88
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Solventum (SOLV) at 3.20 is valued about in line with its industry on P/B ratio, while Insulet (PODD) at 6.44 carries an above-peer premium to book — PODD is pricier on assets.
PODD
Health Care Equipment & Services industry group
6.44
- Max
- 11.68
- PODD
- 6.44
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
SOLV
Health Care Equipment & Services industry group
3.20
- Max
- 11.68
- Q3
- 6.12
- SOLV
- 3.20
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | PODD | SOLV |
|---|---|---|
| P/E Ratio (TTM) | 23.94 | 101.55 |
| P/S Ratio (TTM) | 3.19 | 1.88 |
| P/B Ratio (MRQ) | 6.44 | 3.20 |
| Free Cash Flow Yield (TTM) | 1.12% | 1.31% |